UK Vaccines Business Pushes Wockhardt To Sales Growth

Company ‘Makes about 80% Of The AstraZeneca Vaccine’

 
• By Dean Rudge

Having a year ago radically altered its business by offloading operations in India to rival Dr Reddy’s, India’s Wockhardt saw another burst of sales in the UK, amid its tie-up with AstraZeneca for the COVID-19 vaccine.

COVID coronavirus impact graph recovery
Wockhardt reported a pre-tax loss despite its sales growth • Source: Alamy

More from Earnings

More from Business